Million Women Study Substantiates Link Between HRT and Breast Cancer

Leslie Carol Botha: Finally another independent study that support the 2002 finding of the Women’s Health Institute findings. Women on synthetic hormone birth control…. beware one day independent studies on synthetic hormones in pills, injections and injections will be proving the same thing. Independent studies (different from Pharma sponsored studies) cost millions of dollars and take years to conduct. It has been 10 years since the WHI findings. Medical consumer beware.  Synthetic hormones for birth control are the largest uncontrolled experiments in medical history.



Million Women Study Supports Correlation between Hormone Replacement Therapy in Treating Menopause Symptoms and Cancer

Beverly Hills, Calif., Aug. 30, 2012

The Million Women Study is a study, conducted by UK researchers, of women’s health analyzing data from more than one million women aged 50 and over. It is a collaborative project between Cancer Research UK and the National Health Service (NHS), with additional funding from the Medical Research Council (UK). The study has abundantly fulfilled its aims of illuminating the answers to crucial questions about factors affecting the health of women in this age group as its collaborators continue their frequent contributions to prestigious medical journals of what has become an impressive series of landmark medical papers.

Eaton Scientific Systems, Ltd. CEO, Michael Borkowski, says that “the Million Women Study, is both alarming and important to the need for non-hormonal treatments like Eaton’s Tropine 3 in dealing with pre-menopause, menopause and peri-menopause symptoms affecting millions of women in the US and around the world who do not want to risk using hormonal treatments because of their potential relationship with cancer.”

One key focus of the study relates to the effects of hormone replacement therapy use on women’s health. The study has confirmed the findings in the Women’s Health Initiative (WHI) that women currently using Hormonal Replacement Therapy (“HRT”) are more likely to develop breast cancer than those who are not using HRT.

Results from the Million Women Study, together with those of the WHI trial from the USA, have influenced national policy, including recent recommendations on the prescribing and use of hormone replacement therapy from the Royal College of Obstetricians and Gynecologists and from the Commission on Human Medicines.

The Million Women Study is a multi-center, population-based prospective cohort study of women aged 50 and over for routine breast cancer screening in the UK. Between 1996 and 2001, women were invited to join the Million Women Study when they received their invitation to attend breast screening at one of 66 participating NHS Breast Screening Centers in the UK. At these centers, women received a study questionnaire with their invitation which they were asked to complete and return at the time of screening. Approximately 70% of those attending the program returned questionnaires and agreed to take part in the study, which represented over 1 in 4 women in the UK in the target age group. The Million Women Study is the largest study of its kind in the world.

HRT and Breast Cancer

Follow-up of over 1 million women in the Million Women Study confirmed findings from other recent studies that women currently using HRT are more likely to develop breast cancer than those who are not using HRT. Past users are not at increased risk. The study was able to show that this effect is substantially greater for combined (estrogen-progestagen) HRT than for estrogen-only HRT; and that the effects were similar for all specific types and doses of estrogen and progestagen, for oral, transdermal and implanted HRT, and for continuous and sequential patterns of use. Current users of estrogen-progestagen HRT were at 2 fold increased risk of developing breast cancer, and current users of estrogen-only HRT at 1.3 fold risk. Use of HRT by women aged 50–64 in the UK in the decade from 1993-2003 resulted in an estimated 20,000 extra breast cancers.


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.